SUPN · Healthcare · $2.5B
$43.04-2.12%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 60 Drug Manufacturers - Specialty & Generic peers
Quarterly Revenue Growth
“이번 분기에서 가장 눈에 띄는 건 ZURZUVAE(산후우울증 치료제)예요.”
In the company's words · 2026 1분기 earnings call